Metabolon Response to the Coronavirus
March 13, 2020
To Our Valued Clients:
The world’s eyes are on COVID-19 (the coronavirus) and the situation continues to impact all our communities. I want to personally update you on the steps we have taken to ensure business continuity for each one of our customers.
First and foremost, the health and wellness of our staff is paramount. We have adopted the appropriate business practices to keep our employees safe, including remote working where possible, social distancing on-site through staggered shifts and increased separation between work stations, as well as increased personal and site disinfecting.
I want to assure you that we are absolutely committed to providing uninterrupted project delivery for our clients and maintaining the exceptional customer service and actionable insights you expect from us. Based on our testing of these adapted business practices, we expect to maintain business as normal and delivery of committed project timelines.
While the challenges of the current environment are new for us all, we will continue to monitor the changing situation daily and adjust our business processes accordingly. In the meantime, please do not hesitate to reach out to your business development representative or other key contacts at Metabolon should you have any questions about a current study, or require assistance initiating new projects. We also have set up a FAQ page on our website providing some more detailed information.
Thank you for your continued trust in Metabolon for your metabolomics needs. We look forward to working closely with our clients during this uncertain time to ensure you can continue your important research to advance scientific innovations that enable a healthier world.
Rohan (Ro) Hastie
President & CEO